221 related articles for article (PubMed ID: 22583829)
1. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis.
Sun Z; Luo Q; Ye D; Chen W; Chen F
Mol Cancer; 2012 May; 11():33. PubMed ID: 22583829
[TBL] [Abstract][Full Text] [Related]
2. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
Szczepanski MJ; Czystowska M; Szajnik M; Harasymczuk M; Boyiadzis M; Kruk-Zagajewska A; Szyfter W; Zeromski J; Whiteside TL
Cancer Res; 2009 Apr; 69(7):3105-13. PubMed ID: 19318560
[TBL] [Abstract][Full Text] [Related]
3. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.
Szajnik M; Szczepanski MJ; Czystowska M; Elishaev E; Mandapathil M; Nowak-Markwitz E; Spaczynski M; Whiteside TL
Oncogene; 2009 Dec; 28(49):4353-63. PubMed ID: 19826413
[TBL] [Abstract][Full Text] [Related]
4. GEF-H1-RhoA signaling pathway mediates LPS-induced NF-κB transactivation and IL-8 synthesis in endothelial cells.
Guo F; Tang J; Zhou Z; Dou Y; Van Lonkhuyzen D; Gao C; Huan J
Mol Immunol; 2012 Feb; 50(1-2):98-107. PubMed ID: 22226472
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.
Wang L; Zhao Y; Qian J; Sun L; Lu Y; Li H; Li Y; Yang J; Cai Z; Yi Q
Cancer; 2013 Feb; 119(4):782-91. PubMed ID: 22915070
[TBL] [Abstract][Full Text] [Related]
6. circ_0001461 promotes oral squamous cell carcinoma progression through miR-145/TLR4/NF-κB axis.
Ai Y; Song J; Wei H; Tang Z; Li X; Lv X; Luo H; Wu S; Zou C
Biochem Biophys Res Commun; 2021 Aug; 566():108-114. PubMed ID: 34119822
[TBL] [Abstract][Full Text] [Related]
7. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
Zhu R; Mao Y; Xu X; Li Y; Zheng J
Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
[TBL] [Abstract][Full Text] [Related]
8. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
9. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
10. LPS induces IL-8 expression through TLR4, MyD88, NF-kappaB and MAPK pathways in human dental pulp stem cells.
He W; Qu T; Yu Q; Wang Z; Lv H; Zhang J; Zhao X; Wang P
Int Endod J; 2013 Feb; 46(2):128-36. PubMed ID: 22788664
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
[TBL] [Abstract][Full Text] [Related]
12. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.
Medvedev AE; Piao W; Shoenfelt J; Rhee SH; Chen H; Basu S; Wahl LM; Fenton MJ; Vogel SN
J Biol Chem; 2007 Jun; 282(22):16042-53. PubMed ID: 17392283
[TBL] [Abstract][Full Text] [Related]
13. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways.
Zhou CH; Zhu YZ; Zhao PP; Xu CM; Zhang MX; Huang H; Li J; Liu L; Wu YQ
Anesth Analg; 2015 Jun; 120(6):1361-8. PubMed ID: 25695672
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines.
Tano T; Okamoto M; Kan S; Nakashiro K; Shimodaira S; Yamashita N; Kawakami Y; Hamakawa H
Oral Oncol; 2012 Aug; 48(8):678-85. PubMed ID: 22387210
[TBL] [Abstract][Full Text] [Related]
15. miR-195 Inhibits Proliferation and Enhances Apoptosis of OSCC Cells via Targeting TLR4.
Wang J; Song R; Wang C; Zhang S; Zhang Y; Zhu Y; Zhao G
J Healthc Eng; 2022; 2022():2270777. PubMed ID: 35310196
[TBL] [Abstract][Full Text] [Related]
16. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
[TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory Activity of Adenosine 5'-Trisphosphate in Lipopolysaccharide-Stimulated Human Umbilical Vein Endothelial Cells Through Negative Regulation of Toll-Like Receptor MyD88 Signaling.
Luo X; Xiao B; Xiao Z
DNA Cell Biol; 2019 Dec; 38(12):1557-1563. PubMed ID: 31580158
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide enhances decorin expression through the Toll-like receptor 4, myeloid differentiating factor 88, nuclear factor-kappa B, and mitogen-activated protein kinase pathways in odontoblast cells.
He W; Qu T; Yu Q; Wang Z; Wang H; Zhang J; Smith AJ
J Endod; 2012 Apr; 38(4):464-9. PubMed ID: 22414830
[TBL] [Abstract][Full Text] [Related]
20. TLR4 signaling promotes immune escape of human colon cancer cells by inducing immunosuppressive cytokines and apoptosis resistance.
Tang X; Zhu Y
Oncol Res; 2012; 20(1):15-24. PubMed ID: 23035361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
